Cargando…
Expression of androgen receptor splice variants in clinical breast cancers
The importance of androgen receptor (AR) signaling is increasingly being recognized in breast cancer, which has elicited clinical trials aimed at assessing the efficacy of androgen deprivation therapy (ADT) for metastatic disease. In prostate cancer, resistance to ADT is frequently associated with t...
Autores principales: | Hickey, Theresa E., Irvine, Connie M., Dvinge, Heidi, Tarulli, Gerard A., Hanson, Adrienne R., Ryan, Natalie K., Pickering, Marie A., Birrell, Stephen N., Hu, Dong Gui, Mackenzie, Peter I., Russell, Roslin, Caldas, Carlos, Raj, Ganesh V., Dehm, Scott M., Plymate, Stephen R., Bradley, Robert K., Tilley, Wayne D., Selth, Luke A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792588/ https://www.ncbi.nlm.nih.gov/pubmed/26554309 |
Ejemplares similares
-
Systematic and functional characterization of novel androgen receptor variants arising from alternative splicing in the ligand-binding domain
por: Uo, T, et al.
Publicado: (2017) -
Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors
por: Gillis, Joanna L., et al.
Publicado: (2013) -
Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy
por: Cao, Bo, et al.
Publicado: (2014) -
MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand
por: Liu, Gang, et al.
Publicado: (2014) -
Intracrine androgen biosynthesis and drug resistance
por: Penning, Trevor M., et al.
Publicado: (2020)